Latest News

Adjuvant Erlotinib Fails to Prolong Disease-Free Survival in EGFR-Expressing Lung Cancer

Adjuvant Erlotinib Fails to Prolong Disease-Free Survival in EGFR-Expressing Lung Cancer

Adjuvant erlotinib did not prolong-disease-free survival in patients with EGFR-expressing non-small cell lung cancer (NSCLC).

FOLFOXIRI Plus Bevacizumab Feasible for Some with Colorectal Cancer

FOLFOXIRI Plus Bevacizumab Feasible for Some with Colorectal Cancer

Fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus bevacizumab is a feasible treatment for some with metastatic colorectal cancer (mCRC).

Rates for Palliative Care Consultation Low Regardless of Race, Ethnicity

Rates for Palliative Care Consultation Low Regardless of Race, Ethnicity

Rates of inpatient palliative care consultation remain low and occur close to death irrespective of race/ethnicity.

Sonography, MRI Comparable for Cervical Cancer Staging

Sonography, MRI Comparable for Cervical Cancer Staging

Transvaginal sonography (TVS) is comparable to magnetic resonance imaging (MRI) for diagnosing and staging local cervical cancer.

Gemcitabine Plus Docetaxel May Be Better Tolerated for Localized Soft Tissue Sarcoma

Gemcitabine Plus Docetaxel May Be Better Tolerated for Localized Soft Tissue Sarcoma

Gemcitabine plus docetaxel was associated with a nonsignificant lower hospitalization rate in localized, high grade soft tissue sarcoma.

In Cutaneous Melanoma, Early Sentinel-Node Biopsy Associated with Poorer Survival

In Cutaneous Melanoma, Early Sentinel-Node Biopsy Associated with Poorer Survival

Early sentinel-node biopsy is associated with poorer survival than delayed biopsy in patients with cutaneous melanoma.

Single Organ Metastases in NSCLC Linked with Better Outcomes

Single Organ Metastases in NSCLC Linked with Better Outcomes

Patients with single organ metastatic stage 4 non-small cell lung cancer (NSCLC), especially those with low TN status, have favorable prognosis.

In Breast Cancer, Physician Peers Influence Treatment Adoption

In Breast Cancer, Physician Peers Influence Treatment Adoption

Physicians whose peers were early adopters of brachytherapy for early-stage breast cancer more likely to adopt the therapy themselves.

Association of 21-Gene Recurrence Score Assay, Chemo in Early-stage Breast Cancer

Association of 21-Gene Recurrence Score Assay, Chemo in Early-stage Breast Cancer

Adoption of the 21-gene recurrence score assay on receipt of chemotherapy was strongly population dependent.

In Heavily Pretreated Refractory Myeloma, Daratumumab May Be Safe, Effective

In Heavily Pretreated Refractory Myeloma, Daratumumab May Be Safe, Effective

Daratumumab monotherapy had a favorable safety profile and encouraging efficacy in heavily pretreated and refractory multiple myeloma.

In Locoregionally Advanced Oral Cavity Cancer, Preop Induction Chemo May Not Improve Outcomes

In Locoregionally Advanced Oral Cavity Cancer, Preop Induction Chemo May Not Improve Outcomes

Induction chemotherapy administered before surgery with curative intent did not improve outcomes in locoregionally advanced oral cavity cancer.

Patients With Solid Tumors Face Risk for Critical Illness

Patients With Solid Tumors Face Risk for Critical Illness

In a Scottish population, about 5% of patients who were diagnosed with solid cancers experienced critical illness.

Dasatinib Plus Chemo Achieves Long-Term Remission in Ph+ Acute Leukemia

Dasatinib Plus Chemo Achieves Long-Term Remission in Ph+ Acute Leukemia

Combination of chemotherapy with dasatinib is effective in achieving long-term remission for in Ph+ acute lymphoblastic leukemia (ALL).

Patupilone Shows Activity in Recurrent NSCLC Brain Metastases

Patupilone Shows Activity in Recurrent NSCLC Brain Metastases

Patupilone demonstrated activity in heavily pretreated patients with recurrent brain metastases from non-small cell lung cancer (NSCLC).

How Many People Does it Take to Increase Colorectal Cancer Screening to 80%?

How Many People Does it Take to Increase Colorectal Cancer Screening to 80%?

Approximately 277,000 colorectal cancer (CRC) cases and 203,000 CRC deaths can be averted if screening and prevalence to 80% is reached.

Blood Test May Predict Relapse in Early-Stage Breast Cancer

Blood Test May Predict Relapse in Early-Stage Breast Cancer

An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed.

ERCC1 Genotype Can Identify Good Prognosis in Nasopharyngeal Cancer

ERCC1 Genotype Can Identify Good Prognosis in Nasopharyngeal Cancer

Excision repair cross-complementing group 1 (ERCC1) genotype may identify favorable prognosis for subgroup of nasopharyngeal carcinoma (NPC).

Most Women Experience Anxiety With False-Positive Mammograms

Most Women Experience Anxiety With False-Positive Mammograms

A majority of women who receive false positives on mammography experience distress and anxiety.

Higher Travel Burden, Non-private Insurance Linked With Less Likelihood for Adjuvant Chemo

Higher Travel Burden, Non-private Insurance Linked With Less Likelihood for Adjuvant Chemo

Increased travel burden is associated with a decreased likelihood of receiving adjuvant chemotherapy for treatment of colon cancer.

Hypertension Not a Predictor for Pazopanib Efficacy

Hypertension Not a Predictor for Pazopanib Efficacy

Pazopanib-induced hypertension did not correlate with outcome in pazopanib-treated soft tissue sarcoma patients.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs